Core Viewpoint - The research conducted by Yale University has successfully developed human pineal gland organoids (hPGO) that can produce melatonin, providing a new platform for studying pineal gland development, circadian rhythm regulation, and their roles in neurodevelopmental and sleep disorders [4][8]. Group 1: Research Findings - The hPGO model can simulate human pineal gland development and produce melatonin [6]. - hPGO responds to norepinephrine signaling that regulates melatonin synthesis [6]. - Transplantation of hPGO can restore systemic melatonin levels in mice with pineal gland removal [6]. - hPGO derived from Angelman Syndrome patients shows impaired pineal gland cells and reduced melatonin production, reflecting developmental pathological features associated with the syndrome [5][6]. Group 2: Methodology - The research team utilized pluripotent stem cells (PSC) to develop hPGO, successfully mimicking the development and function of the pineal gland [5]. - Single-cell RNA sequencing revealed that hPGO contains mature and developing pineal gland cell subpopulations with transcriptional characteristics highly similar to in vivo pineal glands [5]. Group 3: Implications - The development of hPGO provides a robust platform for exploring the roles of the pineal gland in neurodevelopment and sleep disorders, as well as potential applications in disease modeling and cell therapy [8].